A61P
Therapeutic uses of medicines
Official title: Specific therapeutic activity of chemical compounds or medicinal preparations
A61P (Therapeutic uses of medicines) appears on 261,001 US grants and 404,591 published applications in this corpus.
Search patents in A61P- Granted patents
- 261,001
- Published applications
- 404,591
- Assignees
- 59,443
- Inventors
- 427,776
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 314 | 0 |
| 1977 | 461 | 0 |
| 1978 | 782 | 0 |
| 1979 | 621 | 0 |
| 1980 | 774 | 0 |
| 1981 | 905 | 0 |
| 1982 | 840 | 0 |
| 1983 | 711 | 0 |
| 1984 | 952 | 0 |
| 1985 | 1054 | 0 |
| 1986 | 1021 | 0 |
| 1987 | 1155 | 0 |
| 1988 | 1130 | 0 |
| 1989 | 1587 | 0 |
| 1990 | 1582 | 0 |
| 1991 | 1640 | 0 |
| 1992 | 1614 | 0 |
| 1993 | 1321 | 0 |
| 1994 | 1553 | 0 |
| 1995 | 2054 | 0 |
| 1996 | 2439 | 0 |
| 1997 | 3353 | 0 |
| 1998 | 4036 | 0 |
| 1999 | 4571 | 0 |
| 2000 | 4554 | 0 |
| 2001 | 5168 | 1483 |
| 2002 | 5342 | 7222 |
| 2003 | 5163 | 10490 |
| 2004 | 3894 | 12405 |
| 2005 | 3731 | 12418 |
| 2006 | 4953 | 12415 |
| 2007 | 4919 | 12811 |
| 2008 | 5271 | 16835 |
| 2009 | 6076 | 18834 |
| 2010 | 8450 | 21189 |
| 2011 | 8866 | 20101 |
| 2012 | 10664 | 18526 |
| 2013 | 12275 | 15962 |
| 2014 | 12672 | 16164 |
| 2015 | 11939 | 15723 |
| 2016 | 10900 | 16006 |
| 2017 | 11225 | 15290 |
| 2018 | 10502 | 16875 |
| 2019 | 11105 | 18537 |
| 2020 | 11473 | 18082 |
| 2021 | 11018 | 18731 |
| 2022 | 10027 | 19632 |
| 2023 | 8653 | 20116 |
| 2024 | 9445 | 19633 |
| 2025 | 9725 | 16852 |
| 2026 | 6521 | 12259 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Main groups
Granted patents with any code in the group
- A61P 35/00Antineoplastic agents88,627
- A61P 43/00Drugs for specific purposes, not provided for in groups a61p1/00-a61p41/0076,805
- A61P 25/00Drugs for disorders of the nervous system66,566
- A61P 31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics61,665
- A61P 9/00Drugs for disorders of the cardiovascular system53,440
- A61P 37/00Drugs for immunological or allergic disorders50,507
- A61P 29/00Non-central analgesic, antipyretic or antiinflammatory agents48,693
- A61P 3/00Drugs for disorders of the metabolism45,553
All 22 main groupsShow fewer
- A61P 1/00Drugs for disorders of the alimentary tract or the digestive system44,014
- A61P 17/00Drugs for dermatological disorders39,538
- A61P 19/00Drugs for skeletal disorders32,451
- A61P 11/00Drugs for disorders of the respiratory system31,962
- A61P 7/00Drugs for disorders of the blood or the extracellular fluid26,481
- A61P 13/00Drugs for disorders of the urinary system24,810
- A61P 27/00Drugs for disorders of the senses24,757
- A61P 15/00Drugs for genital or sexual disorders17,298
- A61P 21/00Drugs for disorders of the muscular or neuromuscular system15,408
- A61P 5/00Drugs for disorders of the endocrine system13,704
- A61P 33/00Antiparasitic agents8,748
- A61P 39/00General protective or antinoxious agents6,123
- A61P 23/00Anaesthetics2,036
- A61P 41/00Drugs used in surgical methods1,715
Recent patents
- Use of ionic polymers in biomass processing for preparation of animal feed additive6 Oct 2026US 12,751,470 B2Embion Technologies SA
- Liposomal enhanced intra-peritoneal chemotherapy6 Oct 2026US 12,751,919 B2
- Polysaccharide encapsulated oxygen nanobubbles6 Oct 2026US 12,751,927 B2The Board of Trustees of the University of Illinois
- Engineered cells and uses thereof6 Oct 2026US 12,751,929 B2Ohio State Innovation Foundation
- Prevention of viral transmission through feed6 Oct 2026US 12,751,931 B2Dsm IP Assets B.V.
- Method of addressing alzheimer's disease or non-alzheimer's dementia8 Oct 2026US 2026/0305670 A1G. Nofar Food Agency Ltd.
- Methods of determining glucose hypometabolism-induced energy crisis and treatments thereof8 Oct 2026US 2026/0306018 A1Senovia Biosciences LLC
- Cosmetic composition comprising an endolysin and an organic filler8 Oct 2026US 2026/0306385 A1L'oreal
- Aqueous formulations comprising fullerene, structured water, dissolved hydrogen gas, minerals and additives8 Oct 2026US 2026/0306402 A1Best Planet Science LLC
- Liposome compositions and medical uses thereof8 Oct 2026US 2026/0306404 A1
Most cited
By later US patents
- Humanized immunoglobulins2,884US 5,585,089 AProtein Design Labs, Inc. · 1996
- Humanized immunoglobulins2,259US 5,530,101 AProtein Design Labs, Inc. · 1996
- Humanized immunoglobulins2,030US 5,693,762 AProtein Design Labs, Inc. · 1997
- Diabetes management system1,937US 6,544,212 B2Roche Diagnostics GmbH · 2003
- Drug releasing anastomosis devices and methods for treating anastomotic sites1,779US 7,108,701 B2Ethicon, Inc. · 2006